The anticoagulant drug Xarelto has emerged as one of the most popular drugs on the market for preventing blood clots in patients with atrial fibrillation or who recently underwent surgery.
Xarelto, along with competitors Pradaxa and Eliquis, has surpassed stalwart drug warfarin as the go-to option since it doesn’t require regular blood testing or changes to diet. However these newer blood thinners may have more serious risks of internal bleeding.
Like all blood thinning drugs, Xarelto can cause internal bleeding. However, unlike warfarin, there is no reversal agent to stop emergency Xarelto bleeding. This can cause serious injury or death as doctor wait for the effects of the drug to wear off naturally.
Already, Xarelto has been linked to more than 1,000 internal bleeding injuries or deaths. Experts have warned it may be 48% more likely to cause internal bleeding than standard care.
Last month, a Kentucky woman filed the first Xarelto lawsuit alleging the drug caused her several days of hospitalization. A second lawsuit alleged a family member died of uncontrollable internal bleeding after taking Xarelto.
Now, a new warning from the American Medical Association advises Xarelto may be even more dangerous for those also taking common painkillers. It was found taking aspirin or ibuprofen at the same time could double the risk of internal bleeding.
The Institute for Safe Medication Practices has included Xarelto in its annual list of ten most dangerous drugs on the market. The FDA also voted overwhelmingly against approving it for Acute Coronary Syndrome due to bleeding risks.
However, it remains on the market and thousands of patients or families have been hurt without receiving compensation. Now, lawyers are beginning to file lawsuits against the makers of the drug, Bayer and J&J, for those affected.
This past spring, the FDA issued a warning affecting the millions of patients each year that undergo routine gastrointestinal, gynecologic...
In the latest Invokana lawsuit update, DrugNews has learned that a federal judicial panel has transferred new cases alleging...